Sunfox secures Rs 15 Cr in Pre-Series Funding for cardiac innovations

Sunfox is set for rapid expansion in India and globally, focusing on scaling its flagship innovation, Spandan

Health tech startup Sunfox Technologies has raised an additional Rs 15 crore in a pre-series funding round. The round was led by existing investor Venture Catalyst, alongside new investors such as Finvolve through the IA Growth Opportunities Fund I and Brew Opportunities Fund, as well as Universal Group, KP Singhvi Group, and several high-net-worth individuals (HNIs). The funding builds on a previous Rs 5 crore investment from USAID through SAMRIDH Health and LetsVenture, bringing the total raised in this round to Rs 20 crore.

With this new capital, Sunfox is set for rapid expansion in India and globally, focusing on scaling its flagship innovation, Spandan. Spandan is a smartphone-based portable ECG device that provides clinically accurate 12-lead ECG readings, empowering users to detect heart attacks and monitor cardiac health in real-time.

"This capital injection will enable us to scale rapidly, both in India and internationally," said CEO Rajat Jain. "It will fuel our growth and bring Spandan into homes and clinics worldwide. We envision a future where heart attacks are as preventable as fevers, with Spandan becoming as ubiquitous as a household thermometer."